GAO to investigate whether White House influenced COVID-19 vaccine approval process, pandemic response

The Government Accountability Office will probe whether the White House interfered with FDA and CDC operations during the nation’s pandemic response, a group of Senate Democrats announced Oct. 20.

Advertisement

Sens. Elizabeth Warren, D-Mass., Gary Peters D-Mich., and Patty Murray, D-Wash., formally requested the investigation in an Oct. 8 letter in which they cite several alleged examples of White House appointees influencing the FDA and CDC to downplay the pandemic’s severity.

GAO accepted the request in an Oct. 16 letter, writing it would “review whether the CDC and FDA’s scientific integrity and communications policies have been violated and whether those policies are being implemented as intended to assure scientific integrity.” 

The independent watchdog said it would not begin to conduct the investigation for “about three months.” The project has been assigned to Nikki Clowers, the managing director of GAO’s healthcare team. 

More articles on pharmacy:
7 things to know about Pfizer’s COVID-19 vaccine timeline
COVID-19 vaccine acceptance reaches ‘historical level of distrust,’ poll finds
FDA advisory panel to publicly discuss COVID-19 vaccine approval process

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.